78 Results

People

  1. Robson
    Robson
  2. Offit
    Offit
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Patil
    Patil
  6. Berger
    Berger
  7. Ladanyi
    Ladanyi
  8. Stadler
    Stadler
  9. Capanu
    Capanu
  10. Bernstein
    Bernstein

Groups

  1. Biostatistics Service (78)
  2. Breast Medicine Service (78)
  3. Department of Medicine (78)
  4. Epidemiology and Biostatistics (78)
  5. Population Sciences Research Program (78)
  6. Solid Tumor Oncology Division (78)
  7. Survivorship Research (78)
  8. GSK Faculty (47)
  9. Center for Pancreatic Cancer Research (36)
  10. Surgery (34)
  1. "Journal article"
  2. "Biostatistics Service"
  3. "Mark Robson"
Formats
  1. Journal Article (78)
Groups
  1. Biostatistics Service (78)
  2. Breast Medicine Service (78)
  3. Department of Medicine (78)
  4. Epidemiology and Biostatistics (78)
  5. Population Sciences Research Program (78)
  6. Solid Tumor Oncology Division (78)

More Groups

People
  1. Mark Robson (78)
  2. Kenneth Offit (24)
  3. Clifford Hudis (18)
  4. Larry Norton (18)
  5. Sujata Patil (17)
  6. Marinela Capanu (16)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (6)
  4. 2021 (6)
  5. 2020 (7)
  6. 2019 (6)

More Years

Publications
  1. Clinical Cancer Research (7)
  2. Breast Cancer Research and Treatment (5)
  3. Cancer (5)
  4. Breast Cancer Research (4)
  5. JNCI: Journal of the National Cancer Institute (4)
  6. Journal of Clinical Oncology (4)

More Publications

Publishers
  1. American Association for Cancer Research (12)
  2. Springer (8)
  3. Elsevier Inc. (7)
  4. Wiley Blackwell (7)
  5. American Society of Clinical Oncology (6)
  6. Biomed Central Ltd (5)

More Publishers

Results (78)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human evaluation of site-specifically labeled (89)Zr-pertuzumab in patients with HER2-positive breast cancer
    Journal Article

    Yeh, R.; O'Donoghue, J. A.; Jayaprakasam, V. S.; Mauguen, A.; Min, R.; Park, S.; Brockway, J. P.; Bromberg, J. F.; Zhi, W. I.; Robson, M. E.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Comprehensive analysis of germline drivers in endometrial cancer
    Journal Article

    Gordhandas, S.; Rios-Doria, E.; Cadoo, K. A.; Catchings, A.; Maio, A.; Kemel, Y.; Sheehan, M.; Ranganathan, M.; Green, D.; Aryamvally, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • Routine clinical parameters and laboratory testing predict therapy-related myeloid neoplasms after treatment for breast cancer
    Journal Article

    Petrone, G.; Gaulin, C.; Derkach, A.; Kishtagari, A.; Robson, M. E.; Parameswaran, R.; Stein, E. M.
    Haematologica (2023)

    Fulltext@MSK | Save
  • Inherited germline cancer susceptibility gene variants in individuals with non-muscle-invasive bladder cancer
    Journal Article

    Pietzak, E. J.; Whiting, K.; Srinivasan, P.; Bandlamudi, C.; Khurram, A.; Joseph, V.; Walasek, A.; Bochner, E.; Clinton, T.; Almassi, N.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Factors associated with cancer treatment delay among patients diagnosed with COVID-19
    Journal Article

    Mullangi, S.; Aviki, E. M.; Chen, Y.; Robson, M.; Hershman, D. L.
    JAMA Network Open (2022)

    Fulltext@MSK | Save
  • Cancer-causative mutations occurring in early embryogenesis
    Journal Article

    Pareja, F.; Ptashkin, R. N.; Brown, D. N.; Derakhshan, F.; Selenica, P.; da Silva, E. M.; Gazzo, A. M.; Paula, A. D. C.; Breen, K.; Shen, R.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab
    Journal Article

    Ferraro, E.; Singh, J.; Patil, S.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Barrio, A. V.; Malani, R.; Mellinghoff, I. K.; Boire, A.; more...
    npj Breast Cancer (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Multiple primary cancers in patients undergoing tumor-normal sequencing define novel associations
    Journal Article

    Liu, Y. L.; Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Tkachuk, K.; Kemel, Y.; Maio, A.; Belhadj, S.; Carlo, M. I.; Latham, A.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save